168 related articles for article (PubMed ID: 24671701)
21. Acute generalized exanthematous pustulosis in a patient receiving high-dose recombinant interleukin-2.
Gunawardane ND; Vaghani SP; Kuzel TM; Cotliar JA
J Am Acad Dermatol; 2013 Oct; 69(4):e183-4. PubMed ID: 24034391
[No Abstract] [Full Text] [Related]
22. Sustained leukemia-free state and molecular response to sorafenib in a patient with chronic myelomonocytic leukemia in transformation driven by homozygous FLT3-ITD malignant hematopoiesis.
Kosmider O; Chapuis N; Kaltenbach S; Coriat R; Boudou Rouquette P; Willems L; Chesnais V; Radford-Weiss I; Bardet V; Mayeux P; Tamburini J; Fontenay M; Bouscary D
Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):347-50. PubMed ID: 23246161
[No Abstract] [Full Text] [Related]
23. Sorafenib induced eruptive melanocytic lesions.
Uhlenhake EE; Watson AC; Aronson P
Dermatol Online J; 2013 May; 19(5):18184. PubMed ID: 24011281
[TBL] [Abstract][Full Text] [Related]
24. Continuous molecular remission and regression of side effects after discontinuation of salvage therapy with sorafenib and donor lymphocyte infusions in a young patient with relapsed AML.
Ernst J; Schäfer V; Rinke J; Wittig S; Beck JF; Ernst T; Gruhn B
Ann Hematol; 2016 May; 95(6):1027-30. PubMed ID: 26979170
[No Abstract] [Full Text] [Related]
25. Sorafenib-induced acute localized exanthematous pustulosis in a patient with hepatocellular carcinoma.
Liang CP; Yang CS; Shen JL; Chen YJ
Br J Dermatol; 2011 Aug; 165(2):443-5. PubMed ID: 21495998
[No Abstract] [Full Text] [Related]
26. Cardiovascular toxicity and sorafenib: a case report.
García-Lledó J; Cortejoso L; Tenorio Núñez M; Giménez-Manzorro A; Matilla-Peña A; Salcedo-Plaza M; Sanjurjo-Sáez M
Am J Ther; 2014; 21(5):e169-70. PubMed ID: 23676342
[TBL] [Abstract][Full Text] [Related]
27. Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?
Perricone G; Mancuso A; Belli LS; Mazzarelli C; Zavaglia C
Eur J Gastroenterol Hepatol; 2014 May; 26(5):577-8. PubMed ID: 24694739
[No Abstract] [Full Text] [Related]
28. Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report.
Sarradin V; Dalenc F; Sibaud V; Tournier E; Roché H
Clin Breast Cancer; 2018 Oct; 18(5):e743-e746. PubMed ID: 29980428
[No Abstract] [Full Text] [Related]
29. Acute Generalized Exanthematous Pustulosis Induced by Amoxicillin/Clavulanic Acid: Report of a Case Presenting With Generalized Lymphadenopathy.
Syrigou E; Grapsa D; Charpidou A; Syrigos K
J Cutan Med Surg; 2015; 19(6):592-4. PubMed ID: 25997755
[TBL] [Abstract][Full Text] [Related]
30. Acute generalized exanthematous pustulosis induced by docetaxel.
Ji YZ; Geng L; Qu HM; Zhou HB; Xiao T; Chen HD; Wei HC
Int J Dermatol; 2011 Jun; 50(6):763-5. PubMed ID: 21595682
[No Abstract] [Full Text] [Related]
31. The adverse effects of sorafenib in patients with advanced cancers.
Li Y; Gao ZH; Qu XJ
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):216-21. PubMed ID: 25495944
[TBL] [Abstract][Full Text] [Related]
32. Midodrine-induced acute generalized exanthematous pustulosis.
Sadeghpour M; Bunick CG; Robinson DM; Galan A; Tigelaar RE; Imaeda S
Cutis; 2014 May; 93(5):E17-20. PubMed ID: 24897147
[TBL] [Abstract][Full Text] [Related]
33. Daptomycin-induced acute generalized exanthematous pustulosis.
Gordon Spratt EA; Schmidt AN; Kantrow SM
Cutis; 2014 Jun; 93(6):E10-2. PubMed ID: 24999649
[No Abstract] [Full Text] [Related]
34. Acute generalized exanthematous pustulosis induced by clopidogrel.
Ulman CA; Palmer DG; Trevino JJ; Olsen TG; Krishnamurthy S; Gandhi RK
Int J Dermatol; 2014 Oct; 53(10):e461-2. PubMed ID: 24739100
[No Abstract] [Full Text] [Related]
35. [Acute generalized exanthematous pustulosis. Study of 22 cases].
Mebazaa A; Kort R; Zaiem A; Elleuch D; Moula H; Cheikhrouhou R; Trojjet S; Mokni M; Ben Osman A; Daghfous R
Tunis Med; 2010 Dec; 88(12):910-5. PubMed ID: 21136359
[TBL] [Abstract][Full Text] [Related]
36. Case of sorafenib-induced thyroid storm.
Haraldsdottir S; Li Q; Villalona-Calero MA; Olencki TE; Kendra K; Ing SW
J Clin Oncol; 2013 Jun; 31(16):e262-4. PubMed ID: 23610115
[No Abstract] [Full Text] [Related]
37. Nystatin-induced acute generalized exanthematous pustulosis.
Ocerin-Guerra I; Gomez-Bringas C; Aspe-Unanue L; Ratón-Nieto JA
Actas Dermosifiliogr; 2012 Dec; 103(10):927-8. PubMed ID: 23149047
[No Abstract] [Full Text] [Related]
38. Acute generalized exanthematous pustulosis induced by oral prednisolone.
Ishii S; Hasegawa T; Hirasawa Y; Tsunemi Y; Kawashima M; Ikeda S
J Dermatol; 2014 Dec; 41(12):1135-6. PubMed ID: 25327275
[No Abstract] [Full Text] [Related]
39. Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption.
Errichetti E; Pegolo E; Stinco G
J Am Acad Dermatol; 2016 Feb; 74(2):e29-31. PubMed ID: 26775791
[No Abstract] [Full Text] [Related]
40. Acute generalized exanthematous pustulosis induced by celecoxib.
Lee SK; Lee DY; Kim DJ; Kim MS; Lee UH; Hahm JH
J Cutan Pathol; 2016 Jan; 43(1):80-1. PubMed ID: 26488335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
